PFBT
NVRO

Parkside Financial Bank & Trust’s NEVRO CORP. NVRO Stock Holding History

Parkside Financial Bank & Trust’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-123
Closed -$12K – 1569
2017
Q1 		$12K Buy
123
+14
+13% +$1.27K 0.01% 662
2016
Q4 		$8K Buy
+109
New +$9.33K ﹤0.01% 757

Other funds holding NVRO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Parkside Financial Bank & Trust's NVRO Position: Q2 2017 in Review

Parkside Financial Bank & Trust sold out of NEVRO CORP. (NVRO) in Q2 2017, closing a stake of 123 shares — an estimated $12K sold.

Parkside Financial Bank & Trust first reported a position in NVRO in Q4 2016 and held it in 2 quarters. The position peaked at $12K in Q1 2017. 201 funds tracked by Wall St. Rank hold NVRO as of Q2 2017.

  • Parkside Financial Bank & Trust reported no remaining NEVRO CORP. position as of Q2 2017 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 123 NEVRO CORP. shares in Q2 2017, an estimated $12K.
  • Parkside Financial Bank & Trust first reported a position in NEVRO CORP. in Q4 2016 and held it in 2 quarters.
  • Parkside Financial Bank & Trust's NEVRO CORP. position peaked at $12K in Q1 2017.
  • 201 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2017.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2017, filed 27 Jul 2017.